Century Therapeutics, Inc. (IPSC) Insider Ownership

Historic Insider Ownership Trends

IPSC's three largest insider shareholders as of April 17, 2026 are Venture Capital Vi, L.P. Versant (TenPercentOwner, 11.45Mn shares), Venture Capital Vi, L.P. Versant (TenPercentOwner, 11.45Mn shares), Brent Pfeiffenberger (President And Ceo, 3.71Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Venture Capital Vi, L.P. Versant - 11,452,014 0 11 Aug, 2022
Venture Capital Vi, L.P. Versant - 11,452,014 0 11 Aug, 2022
Brent Pfeiffenberger President And Ceo 3,710,958 0 13 Mar, 2026
Brent Pfeiffenberger President And Ceo 3,710,958 0 13 Mar, 2026
Chad Cowan Chief Scientific Officer 1,175,680 0 03 Apr, 2026
Chad Cowan Chief Scientific Officer 1,175,680 0 03 Apr, 2026
Gregory Russotti - 515,427 0 16 Mar, 2026
Gregory Russotti - 515,427 0 16 Mar, 2026
Douglas Carr Svp Finance Operations 507,261 0 16 Mar, 2026
Luis Borges Chief Scientific Officer 256,535 0 05 Apr, 2023
Michael Craig Diem Chief Financial Officer 253,533 0 03 Nov, 2023
Adrienne Farid Chief Operations Officer 250,141 0 11 Jun, 2025
Adrienne Farid Chief Operations Officer 250,141 0 11 Jun, 2025
Morgan Conn Chief Finanical Officer 79,648 0 12 Mar, 2025
Morgan Conn Chief Finanical Officer 79,648 0 12 Mar, 2025
Hyam Levitsky President Of Rd 24,000 0 11 Mar, 2024
Daphne Quimi - 5,000 0 16 Sep, 2024
Daphne Quimi - 5,000 0 16 Sep, 2024

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
01 Apr, 2026 Chad Cowan Common Stock D 1,365 $2.19 1,175,680 D F
12 Mar, 2026 Douglas Carr Common Stock D 7,043 $2.55 507,261 D S
12 Mar, 2026 Gregory Russotti Common Stock D 10,076 $2.55 515,427 D S
11 Mar, 2026 Chad Cowan Common Stock D 1,431 $2.73 1,177,045 D F
11 Mar, 2026 Brent Pfeiffenberger Common Stock D 55,397 $2.73 3,710,958 D F
09 Mar, 2026 Gregory Russotti Common Stock D 479 $2.54 525,503 D S
09 Mar, 2026 Douglas Carr Common Stock D 247 $2.54 514,304 D S
06 Mar, 2026 Brent Pfeiffenberger Common Stock D 463 $2.56 3,766,355 D F
13 Feb, 2026 Brent Pfeiffenberger Common Stock D 31,172 $1.75 3,766,818 D F
03 Feb, 2026 Douglas Carr Common Stock D 323 $1.82 514,551 D S
02 Feb, 2026 Brent Pfeiffenberger Common Stock A 475,000 $0.00 3,797,990 D A
02 Feb, 2026 Gregory Russotti Common Stock A 135,000 $0.00 525,982 D A
02 Feb, 2026 Douglas Carr Common Stock A 110,000 $0.00 514,874 D A
02 Feb, 2026 Chad Cowan Common Stock A 135,000 $0.00 1,178,476 D A
02 Feb, 2026 Brent Pfeiffenberger Stock Option (right to buy) A 945,000 $0.00 945,000 D A
02 Feb, 2026 Douglas Carr Stock Option (right to buy) A 225,000 $0.00 225,000 D A
02 Feb, 2026 Gregory Russotti Stock Option (right to buy) A 265,000 $0.00 265,000 D A
02 Feb, 2026 Chad Cowan Stock Option (right to buy) A 265,000 $0.00 265,000 D A
02 Jan, 2026 Chad Cowan Common Stock D 1,611 $1.00 1,043,476 D F
22 Dec, 2025 Chad Cowan Common Stock A 58,060 $0.85 1,045,087 D P